SRRK

Conviction 98HealthcareScan · Mon, Aug 10, 2026

SRRK$51.89-1.96%

ResistanceSupportVol 14Insider sell

Vol MA14 1.36M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Scholar Rock Holding CorpBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.scholarrock.com ↗

Price51.89

Change-1.96%

Gap-1.11%

Rel volume3.73×

Avg volume1.21M

Avg $ vol60.95M

SMA 2050.10

SMA 5050.04

SMA 20045.29

Price vs 50+3.68%

Price vs 200+14.56%

MA stackbullish

50/200 cross—

Supertrenddown · 53.35

RSI (14)54

MACD hist0.32

MACD crossbull · 1d

Stoch %K / %D77 / 85

ADX (14)23

+DI / −DI22 / 17

RSI divergence—

MACD divergenceBullish

ATR %+4.84%

ADR %4.69%

52w high57.94

52w low27.92

From 52w high-10.45%

Above 52w low+85.83%

New 52w highNo

SqueezeOff

Bollinger width18.54%

%B0.69

Donchian pos63.26%

Donchian high55.46

Donchian low45.73

AVWAP (52w high)50.76

vs AVWAP high+2.21%

AVWAP (52w low)46.17

vs AVWAP low+12.37%

OBV trendDown

Chaikin MF (20)-0.05

Today vs 20d3.73×

Avg vol (14d)1.36M

Avg vol (20d)1.21M

Avg $ vol (20d)60.95M

Market cap—

RS 3m (vs SPY)+8.23%

RS 6m (vs SPY)+4.94%

RS line new highNo

Trend template8/8

Technical rank63.3

1 week+13.16%

1 month-8.51%

3 months+7.22%

6 months+8.96%

1 year+65.27%

YTD+21.23%

P/E-17.06

P/B25.40

P/S—

P/FCF-21.44

EPS-3.29

Div yield—

ROE-148.92%

ROA-72.19%

Debt/Eq0.78

Current7.02

EV/EBITDA-16.21

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth-53.45%

Price target61.40

Target upside15.99%

Analyst ratingBuy

Institutional122.07%

Ent. value6.21B

Revenue0

Net income-109.9M

Gross profit—

Free cash flow-300.64M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out119.83M

Employees289

ListedThu, May 24, 2018

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction98 / 100

Pattern quality—

Tech rank63.3 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance57.52

Support46.50

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SRRK

All disclosures →

No recent disclosed trades by Congress in SRRK. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SRRK · 9 buys

Insider	Side	Shares	Value	Traded	Filed
Reed Joshua Director · Common Stock · 2026-06-04	Grant	6.84K	$0	2026-06-04	2026-06-08
Burow Kristina Director · Stock Option (Right to Buy) · 2026-06-04	Grant	4.31K	$0	2026-06-04	2026-06-08
Peng Katie Director · Stock Option (Right to Buy) · 2026-06-04	Grant	4.31K	$0	2026-06-04	2026-06-08
AKKARAJU SRINIVAS Director · Common Stock · 2026-06-04	Other	—	—	2026-06-04	2026-06-08
AKKARAJU SRINIVAS Director · Common Stock · 2026-06-04	Grant	6.84K	$0	2026-06-04	2026-06-08
Burow Kristina Director · Common Stock · 2026-06-04	Grant	6.84K	$0	2026-06-04	2026-06-08
AKKARAJU SRINIVAS Director · Stock Option (Right to Buy) · 2026-06-04	Grant	4.31K	$0	2026-06-04	2026-06-08
FLIER JEFFREY S. Director · Stock Option (Right to Buy) · 2026-06-04	Grant	4.31K	$0	2026-06-04	2026-06-08
Peng Katie Director · Common Stock · 2026-06-04	Grant	6.84K	$0	2026-06-04	2026-06-08
Gilman Michael Director · Stock Option (Right to Buy) · 2026-06-04	Grant	4.31K	$0	2026-06-04	2026-06-08

SEC filings

EDGAR filings in SRRK · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.